Literature DB >> 17033273

Randomized, double-blind comparison of acute beta1-blockade with 50 mg metoprolol tartrate vs 25 mg carvedilol in normal subjects.

Rana Billeh1, David Hirsh, Colin Barker, Birgit Jorgensen, Raban Jeger, Krishnan Ramanathan, Chi-Hong Tseng, Alhakam Hudaihed, Francois Haas, Ulrich P Jorde.   

Abstract

Differential efficacy of immediate-release metoprolol tartrate and carvedilol in the treatment of congestive heart failure remains a subject of ongoing debate. The degree of beta1-blockade can be assessed by percentage reduction of exercise heart rate. Twelve healthy subjects underwent symptom-limited cardiopulmonary exercise testing repeated weekly and 2 hours after randomized, double-blind administration of 50 mg metoprolol tartrate vs 25 mg carvedilol. Baseline heart rate, heart rate at 40% and 70% peak O2 consumption, and maximal exercise were significantly blunted more by metoprolol tartrate than by carvedilol (P<.05 for all). Peak O2 consumption was significantly reduced by metoprolol tartrate (P<.03) but not by carvedilol (P=.054). The change in O2 consumption was significantly correlated with the degree of beta1-blockade (r =0.45; P<.05). In healthy subjects, a higher degree of beta1-blockade is achieved with 50 mg metoprolol tartrate compared with 25 mg carvedilol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17033273     DOI: 10.1111/j.1527-5299.2006.05496.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  2 in total

1.  Different cardiovascular responses to a resistance training session in hypertensive women receiving propanolol compared with normotensive controls.

Authors:  Fabiano Moraes Miguel; Luis Alexandre Grings; Guilherme Borges Pereira; Richard Diego Leite; Amilton Vieira; Nuno Manuel Frade de Sousa; Roberto Simão; Jonato Prestes
Journal:  ScientificWorldJournal       Date:  2012-05-03

2.  Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review.

Authors:  Dagmar Tučková; Miloslav Klugar; Eliška Sovová; Markéta Sovová; Lenka Štégnerová
Journal:  BMJ Open       Date:  2016-06-15       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.